/LH
Labcorp Holdings Inc.
LH • NYSELH • NYSE • Healthcare
$263.80+0.34%+0.89
$263.80+0.34%(+0.89)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
87Bullish
Risk
81Low Risk
Momentum
44Neutral
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
26.8%▼1.1pp
Revenue after COGS
Operating
10.9%▲2.5pp
After operating expenses
Net
6.3%▲0.5pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
23.8
Price vs earnings
EV/EBITDA
13.7
Enterprise value
FCF Yield
5.8%
Cash generation
Earnings Yield
4.2%
Inverse of P/E
Capital Efficiency
8
GoAI Quality ScoreWeak
ROEReturn on Equity
10.2%Fair
ROAReturn on Assets
4.8%Fair
ROICReturn on Invested Capital
7.4%Fair
Financial Health
Current RatioAdequate
1.42
Short-term solvency (>1.5)
Net Debt / EBITDAHigh
3.31x
Debt repayment capacity (<3x)
Income QualityStrong
1.87
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B |
| Gross Profit | $3.73B | $3.62B | $3.36B | $3.71B | $4.99B |
| Gross Margin | 26.8% | 27.9% | 27.7% | 31.3% | 38.0% |
| Operating Income | $1.52B | $1.09B | $725.60M | $1.44B | $3.05B |
| Net Income | $876.50M | $746.00M | $418.00M | $1.28B | $2.38B |
| Net Margin | 6.3% | 5.7% | 3.4% | 10.8% | 18.1% |
| EPS | $10.54 | $8.89 | $4.80 | $14.04 | $24.58 |
Average Price Target
$315.38▲ 19.6% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Labcorp Holdings Inc., the average price target is $315.38, with a high forecast of $342.00 and a low forecast of $290.00. The average price target represents a 19.6% increase from the current price of $263.80.
Highest
$342.00
Average
$315.38
Lowest
$290.00
Rating Distribution
Strong Buy
0
0%
Buy
26
74%
Hold
9
26%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Piper Sandler● Maintain
Neutral
2026-02-24Baird● Maintain
Outperform
2026-02-18JP Morgan● Maintain
Overweight
2026-02-18JP Morgan● Maintain
Overweight
2026-02-06JP Morgan● Maintain
Overweight
2025-11-07UBS● Maintain
Buy
2025-10-29UBS● Maintain
Buy
2025-10-17Mizuho● Maintain
Outperform
2025-10-17Evercore ISI Group● Maintain
Outperform
2025-10-03Barclays● Maintain
Equal Weight
2025-10-02Earnings History & Surprises
BEAT RATE
89%
Last 18 quarters
AVG SURPRISE
+4.7%
EPS vs Estimate
BEATS / MISSES
16/2
Last 18 quarters
LATEST EPS
$4.07
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+3.0%
$4.07 vs $3.95
Q4 '25
+1.2%
$4.18 vs $4.13
Q3 '25
+4.3%
$4.35 vs $4.17
Q2 '25
+2.7%
$3.84 vs $3.74
Q1 '25
+1.8%
$3.45 vs $3.39
Q4 '24
+0.9%
$3.50 vs $3.47
Q3 '24
+4.2%
$3.94 vs $3.78
Q2 '24
+5.7%
$3.68 vs $3.48
Q1 '24
+0.3%
$3.30 vs $3.29
Q4 '23
+0.3%
$3.38 vs $3.37
Q3 '23
-1.4%
$3.42 vs $3.47
Q2 '23
-4.3%
$3.82 vs $3.99
No investor questions available.
Latest News
No news available